BP
ATEX icon

Ballentine Partners’s Anterix ATEX Stock Holding History

Ballentine Partners’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
+2,917
New +$171K ﹤0.01% 791

Other funds holding ATEX

KMC
Kirr Marbach & Co Columbus, Indiana $594M AUM 34% 1-Year Est. Return
FIC
FCG Investment Company Germantown, Tennessee $289M AUM
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.11B AUM 13.1% 1-Year Est. Return

Ballentine Partners's ATEX Position: Q2 2026 in Review

Ballentine Partners opened a new position in Anterix (ATEX) in Q2 2026: 2,917 shares worth $300K. The stake represents ﹤0.01% of the portfolio and ranks #791 among its holdings.

11 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Ballentine Partners held 2,917 shares of Anterix worth $300K as of Q2 2026.
  • Anterix was a new Ballentine Partners position in Q2 2026.
  • Anterix made up ﹤0.01% of Ballentine Partners's portfolio in Q2 2026, its #791 holding.
  • 11 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.